Enagas Soars, AstraZeneca Gains, Pernod Ricard Rises

Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Enagas shares rise as much as 15%, the most in six years, after Spanish regulator CNMC unveiled a draft proposal for gas companies that JPMorgan says is surprisingly positive.
- AstraZeneca shares rise as much as 3.8%, the most in more than six weeks, after the British drugmaker said its experimental drug for chronic obstructive pulmonary disease — a deadly lung condition also known as COPD — helped reduce the worsening of symptoms in two late-stage trials.
- Pernod Ricard shares gain as much as 4.2%, rebounding from Thursday’s losses as the market reacted to a potential acquisition of Jack Daniel’s whiskey owner Brown-Forman

See omnystudio.com/listener for privacy information.

More description

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Enagas shares rise as much as 15%, the most in six years, after Spanish regulator CNMC unveiled a draft proposal for gas companies that JPMorgan says is surprisingly positive.
- AstraZeneca shares rise as much as 3.8%, the most in more than six weeks, after the British drugmaker said its experimental drug for chronic obstructive pulmonary disease — a deadly lung condition also known as COPD — helped reduce the worsening of symptoms in two late-stage trials.
- Pernod Ricard shares gain as much as 4.2%, rebounding from Thursday’s losses as the market reacted to a potential acquisition of Jack Daniel’s whiskey owner Brown-Forman

See omnystudio.com/listener for privacy information.

2026-03-27 4 min Transcript
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.